跳至主要内容
临床试验/NCT05386199
NCT05386199招募中不适用

The Role of Serotonin in Respiratory and Circulatory Failure in Intensive Care Patients

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2022年5月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
250
试验地点
1
主要终点
PPP-serotonin

研究概览

简要总结

Sepsis, cardiac arrest and multiple trauma are potentially life-threatening conditions and common reasons for intensive care unit (ICU) admission. The aim of this study is to investigate the role of the signaling substance serotonin in blood in these conditions.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

PPP-serotonin

时间窗: As soon as possible after ICU admission. No more than 3 days after admission.

Serotonin in platelet poor plasma

次要结局

  • Platelet serotonin(End of first week at ICU, an average of 5 days after admission.)
  • PPP-serotonin(End of first week at ICU, an average of 5 days after admission.)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Morten Rostrup

Senior physician and clinical professor, Department of Acute Medicine

Oslo University Hospital

研究点 (1)

Loading locations...

相似试验